Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioMed X Moves HQ to Heidelberg Innovation Park | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioMed X Moves HQ to Heidelberg Innovation Park

Partnership with BioLabs expands lab access and life sciences collaboration.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Dr. Ann-Kristin Mueller, Site Director, BioLabs Heidelberg, and Dr. Thomas Rückle, Head of Research, BioMed X AG. Image: BioMed X / BioLabs Heidelberg.

BioMed X has announced plans to relocate its global headquarters to LAB22 at Heidelberg Innovation Park, and launched a global partnership with BioLabs, a provider of shared laboratory infrastructure for life science innovators.

Over the coming months, BioMed X will relocate its global headquarters to LAB22, Heidelberg Innovation Park’s newest landmark building for biotechnology, life sciences, and digital innovation. As part of this move, BioMed X’s Heidelberg-based scientific teams will transfer their laboratory operations to the research facilities of BioLabs Heidelberg, located in the same building.

Going forward, both organizations will explore opportunities to combine BioMed X’s expertise in scientific talent sourcing and innovative solution building with BioLabs’ laboratory infrastructure.

“This marks an exciting new chapter for BioMed X,” said Dr. Christian Tidona, Founder and CEO of BioMed X AG. “Our new headquarters at Heidelberg Innovation Park and our partnership with BioLabs give our researchers access to an outstanding scientific environment while allowing us to focus even more strongly on what we do best: identifying the biggest biomedical challenges, attracting exceptional talent, and building innovative solutions for our partners. At the same time, it brings our scientists closer to the startups, investors, and partners that make this ecosystem work, and gives us a strong foundation for our continued international growth.”

“We are excited to welcome BioMed X as our newest tenant at BioLabs Heidelberg. BioMed X constitutes a unique element of the Heidelberg innovation ecosystem, and their dynamic teams will be a fantastic addition to our startup community. We look forward to supporting BioMed X in their growth in Heidelberg and beyond,” said Dr. Johannes Fruehauf, President & CEO, BioLabs Founder & Chairman, LabCentral.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics